BofA raised the firm’s price target on GE HealthCare (GEHC) to $92 from $82 and keeps a Neutral rating on the shares as the firm moves the valuation year out one year to reflect the calendar change while highlighting its medtech picks for 2026.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Vaso announces fifth extension of sales agreement with GE HealthCare
- GE HealthCare to supply over 300 CT scanners across Indonesia
- GE Healthcare Issues $1.25 Billion in Senior Notes
- GE HealthCare price target raised to $105 from $95 at Jefferies
- GE HealthCare price target raised to $88 from $83 at Citi